Bilir, Betül EkizBilir, BülentTakır, Mümtaz2024-10-292024-10-2920162149-2042https://doi.org/10.5222/MMJ.2016.046https://hdl.handle.net/20.500.11776/12561The aim of our study was to evaluate lipoprotein(a) whose plasma levels are mostly under genetic regulation as a risk factor for coronary artery disease in Turkish dyslipidemic patients according to Framingham risk scoring system. Totally 173 high and low-risk dyslipidemic patients according to Framingham risk scoring system were enrolled and association of Lp(a) with major risk factors were studied. At the end of the study, there was not a statistically significant correlation between the Lp(a) level and Framingham risk group. Although there was a statistically significant positive correlation between TG levels and high levels of Lp(a), there were not such a relationship between high levels of Lp(a) and other parameters such as age, sex, HT, DM, smoking status, total cholesterol, HDL cholesterol and LDL cholesterol. © 2018, Logos Medical Publishing. All rights reserved.tr10.5222/MMJ.2016.046info:eu-repo/semantics/openAccessDyslipidemiaFramingham risk scoring systemLipoprotein(a)The value of lipoprotein(A) as a risk factor and its association with major risk factors in high and low-risk dyslipidemic patients according to framingham risk scoring systemFramingham risk skorlama sistemine göre düşük ve yüksek riskli dislipidemik hastalarda lipoprotein(A)’nın risk faktörü olarak değeri ve majör risk faktörleriyle ilişkisiArticle31146522-s2.0-85044110645